Antiretroviral Agents — How Best to Protect Infants from HIV and Save Their Mothers from AIDSHIV/AIDS: global trends, global funds and delivery bottlenecksImplications of acquired environmental enteric dysfunction for growth and stunting in infants and children living in low- and middle-income countriesExclusive breastfeeding, diarrhoeal morbidity and all-cause mortality in infants of HIV-infected and HIV uninfected mothers: an intervention cohort study in KwaZulu Natal, South AfricaChildren who acquire HIV infection perinatally are at higher risk of early death than those acquiring infection through breastmilk: a meta-analysisObituary. Harry Stein, 1925-2014.Preliminary outcomes of a paediatric highly active antiretroviral therapy cohort from KwaZulu-Natal, South AfricaBroad and Gag-biased HIV-1 epitope repertoires are associated with lower viral loads.Scaling-up exclusive breastfeeding support programmes: the example of KwaZulu-Natal.Immunodominant HIV-1 Cd4+ T cell epitopes in chronic untreated clade C HIV-1 infection.Duration, pattern of breastfeeding and postnatal transmission of HIV: pooled analysis of individual data from West and South African cohortsInfant feeding, HIV transmission and mortality at 18 months: the need for appropriate choices by mothers and prioritization within programmesSub-Saharan Africa's mothers, newborns, and children: how many lives could be saved with targeted health interventions?Sub-Saharan Africa's mothers, newborns, and children: where and why do they die?Amino-acid co-variation in HIV-1 Gag subtype C: HLA-mediated selection pressure and compensatory dynamics.Net survival of perinatally and postnatally HIV-infected children: a pooled analysis of individual data from sub-Saharan AfricaRole of traditional birth attendants in preventing perinatal transmission of HIV.Improving child health: the role of research.Unique acquisition of cytotoxic T-lymphocyte escape mutants in infant human immunodeficiency virus type 1 infection.Preventing postnatal mother-to-child transmission of HIV: context mattersAdditive contribution of HLA class I alleles in the immune control of HIV-1 infection.Characterization of anti-HIV-1 neutralizing and binding antibodies in chronic HIV-1 subtype C infectionTwo commentaries on 'Impact of tuberculosis preventive therapy on tuberculosis and mortality in HIV-infected children'HIV-1 subtype C envelope characteristics associated with divergent rates of chronic disease progressionMortality of infected and uninfected infants born to HIV-infected mothers in Africa: a pooled analysis.Time for new recommendations on cotrimoxazole prophylaxis for HIV-exposed infants in developing countries?The association between the ratio of monocytes: lymphocytes and risk of tuberculosis among HIV-infected postpartum womenKaposi's sarcoma-associated herpesvirus-specific immune reconstitution and antiviral effect of combined HAART/chemotherapy in HIV clade C-infected individuals with Kaposi's sarcoma.Mother-to-child transmission of HIV-1 infection during exclusive breastfeeding in the first 6 months of life: an intervention cohort study.Cumulative exposure to cell-free HIV in breast milk, rather than feeding pattern per se, identifies postnatally infected infants.Effect of GB virus C co-infection on response to generic HAART in African patients with HIV-1 clade C infection.Efficacy and safety of an extended nevirapine regimen in infant children of breastfeeding mothers with HIV-1 infection for prevention of postnatal HIV-1 transmission (HPTN 046): a randomised, double-blind, placebo-controlled trial.Mapping sites of positive selection and amino acid diversification in the HIV genome: an alternative approach to vaccine design?Efficacy and safety of an extended nevirapine regimen in infants of breastfeeding mothers with HIV-1 infection for prevention of HIV-1 transmission (HPTN 046): 18-month results of a randomized, double-blind, placebo-controlled trial.Evaluation of adherence measures of antiretroviral prophylaxis in HIV exposed infants in the first 6 weeks of lifeTowards a family-centered approach to HIV treatment and care for HIV-exposed children, their mothers and their families in poorly resourced settings.Use of antiretroviral drugs to prevent HIV-1 transmission through breast-feeding: from animal studies to randomized clinical trials.Perinatal tuberculosis and HIV-1: considerations for resource-limited settings.Drug resistance and coreceptor usage in HIV type 1 subtype C-infected children initiating or failing highly active antiretroviral therapy in South Africa.Extended prophylaxis with nevirapine and cotrimoxazole among HIV-exposed uninfected infants is well tolerated.
P50
Q22250894-8CA0B932-BA74-45B9-8864-105410EE9810Q24811612-C9F337CA-8B04-4020-8CFB-D130B3FF198AQ27016503-284950CF-31A3-4417-A63B-2ACC02A434C9Q28535608-039EA36F-1F9F-48A4-B6C7-D258BF926C3DQ28731813-FC2216E4-C156-40A0-843F-6ADB38692DAFQ30380078-CBF89E70-8EDC-4C56-803F-371D66E4CE7BQ33279183-1E7609AF-3CDC-4B20-8870-AEEE94AF4AF5Q33313878-2D40AB04-B42B-4B29-8BCC-82AE3F604978Q33344527-F9029E81-7D91-409F-A488-6ABBCB97337FQ33427803-0FFDFDD4-4824-43E6-99F0-5F1C9BF527D5Q33510928-BFE739F3-1E87-4E04-BB35-9146463052B6Q33572219-4457A148-946C-493C-B47B-1C5C86AAEC88Q33614631-D40F0B93-7C22-46CF-B4CE-93078F6C6D9FQ33614662-7448E672-AE21-423D-B240-D7EE024E714BQ33687232-7FBE4291-EAE8-470E-8051-C9CFBCC77BEBQ33797490-E3B03B28-C20A-4975-9EC0-F51749165479Q33808843-069759CA-6F3A-45F3-BEB6-F4D4DA9B198DQ33810830-A8B5199C-564F-4C0A-A00C-8A393B025F05Q33987347-9D3416E7-E164-482F-99EE-7E089DF2BA5CQ33996702-DFA969FC-9F71-4AF3-9592-ECA506E7C344Q34120809-859D534F-9DCE-41AF-BD48-C90DDC322ABBQ34300812-65FC102F-4FAB-43EE-90AF-5DF5B9EBD122Q34322143-168B6807-1A3E-4791-8739-9D34E718520AQ34350944-F8142202-65F2-4E55-BCB2-E34BE84CCA43Q34355499-76054469-A793-46F9-874A-D8D073AEF9DEQ34368707-E73A8838-CCB9-4038-93BA-1309DD7FB0DFQ34498482-D2911251-BE77-4491-B80C-E5873B89D996Q34579974-8A1B94D4-5FDC-484A-882A-DB19E0AAF0A8Q34614259-61A26092-20E7-4D44-ACBE-A55F18C13751Q34626961-DA0CB18B-566E-44B4-A9A7-3740F45555FDQ34633937-B49711FC-9423-4B8B-8A78-160BEEA776FAQ34634644-78A07CCD-1E18-40D4-BE8B-DF6AE7AF6A55Q34645213-2B40BE0F-A932-46F3-AD0B-9F516AE48253Q34657178-01D117AE-718B-498F-BB37-217CFE4EF356Q35238134-B2ECA6F2-5216-4535-9951-10541122AAD3Q35327004-89DD9417-FBC8-45E2-89D1-E39683BF8FDBQ35628415-ADF5D37D-0193-4472-9A53-0D1E8BB50650Q35681335-4EDCDE7E-0AE9-480E-AAFE-4CF2BC8F7890Q35862329-54A27831-1C90-4F7A-84E6-2CF8EFAF0AEBQ35974392-FAA59727-1D72-49BD-94DD-0C3C285F60B7
P50
description
arts uit Zuid-Afrika
@nl
dokter asal Afrika Selatan
@id
médicu sudafricanu
@ast
physician
@en
südafrikanischer Arzt
@de
طبيب جنوب أفريقي
@ar
name
Hoosen Coovadia
@ast
Hoosen Coovadia
@en
Hoosen Coovadia
@es
Hoosen Coovadia
@fr
Hoosen Coovadia
@ga
Hoosen Coovadia
@nl
Hoosen Coovadia
@sl
type
label
Hoosen Coovadia
@ast
Hoosen Coovadia
@en
Hoosen Coovadia
@es
Hoosen Coovadia
@fr
Hoosen Coovadia
@ga
Hoosen Coovadia
@nl
Hoosen Coovadia
@sl
altLabel
Coovadia H
@en
Coovadia H.
@en
Coovadia
@en
H Coovadia
@en
H. Coovadia
@en
Hoosen M Coovadia
@en
prefLabel
Hoosen Coovadia
@ast
Hoosen Coovadia
@en
Hoosen Coovadia
@es
Hoosen Coovadia
@fr
Hoosen Coovadia
@ga
Hoosen Coovadia
@nl
Hoosen Coovadia
@sl
P166
P106
P166
P21
P31
P569
1940-01-01T00:00:00Z